DPW
DNLI icon

DiNuzzo Private Wealth’s Denali Therapeutics DNLI Stock Holding History

DiNuzzo Private Wealth’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258 Buy
10
+8
+400% +$164 ﹤0.01% 1223
2026
Q1 		$39 Buy
+2
New +$40 ﹤0.01% 1319
2025
Q2 		– Sell
-2
Closed -$28 – 1375
2025
Q1 		$28 Buy
+2
New +$38 ﹤0.01% 1355

Other funds holding DNLI

EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $833M AUM 22.71% 1-Year Est. Return

DiNuzzo Private Wealth's DNLI Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Denali Therapeutics (DNLI) stake by 400% in Q2 2026, buying an estimated $164 and bringing the position to 10 shares worth $258. The position accounts for ﹤0.01% of the portfolio, ranked #1223.

DiNuzzo Private Wealth first reported a position in DNLI in Q1 2025 and has held it in 3 quarters since. 46 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • DiNuzzo Private Wealth held 10 shares of Denali Therapeutics worth $258 as of Q2 2026.
  • DiNuzzo Private Wealth bought 8 Denali Therapeutics shares in Q2 2026, an estimated $164.
  • Denali Therapeutics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1223 holding.
  • DiNuzzo Private Wealth first reported a position in Denali Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 46 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.